In the first nine months of 2018, the GHG has continued to deliver its key strategic priorities, with mid-teens revenue growth in both the healthcare services and pharmacy and distribution businesses, whilst largely completing the GHG’s significant three-year investment programme.
Gross revenues totalled GEL 622 million for the first nine months of the year, an increase of 13% y-o-y. EBITDA of GEL 95 million represented a 23% increase year on year, and profit before tax increased by 13% over the same period, to GEL 39 million. In the seasonally quiet third quarter of 2018, Group EBITDA totalled GEL 33 million, an increase of 25% year-onyear and 5% quarter-on-quarter.
Healthcare services. In the first nine months, healthcare services revenue grew 14% to GEL 224 million.
GHG is the single largest market participant in the healthcare services industry in Georgia, accounting for 24.9% of the country’s total hospital bed capacity, as of 30 September.
